The EPIC Research Study
Learn about this study for adults with generalized myasthenia gravis (gMG).
The EPIC Research Study
Learn about this study for adults with generalized myasthenia gravis (gMG).
This study is for adults 18 to 74 years old who have been diagnosed with gMG and received previous treatment for gMG.
You can join the study if:
- You are 18 to 74 years of age
- You have been diagnosed with gMG
- You have received previous treatment for gMG
Additional eligibility criteria will apply.
You cannot join the study if:
- You experience severe or chronic infections
- You are participating in another clinical research study
Additional eligibility criteria will apply.
- In order to join the study, you must go through a screening process and meet all eligibility criteria.
- If you agree to participate, you will have regularly scheduled study visits for health exams and tests.
- All study-required visits, tests, and medication will be provided at no cost to you.
- In addition, reimbursement for study-required travel may be provided.
- Participating in this study may help researchers learn more about gMG and the investigational medications
- You could experience one or more side effects during the study
- The study doctor/staff will review a full list of potential risks and possible side effects with you
- You will be closely monitored for any side effects and changes in your health
See if you may qualify
Answer the following questions to see if you or someone you know may be eligible to take part in this study.
Please keep in mind:
Even if you believe you meet the eligibility criteria, joining a clinical trial is not guaranteed. Whether you’re referred or able to take part depends on a review by a qualified healthcare professional. This questionnaire is intended for United States participants only.
Note about privacy:
Email responses may not be encrypted. This means there’s a chance the messages could be seen by someone other than the intended recipient. We will avoid including sensitive personal information in emails whenever possible. However, we cannot guarantee that no sensitive information will be revealed indirectly.
About your information:
With your consent, we will use your answers to help determine whether you may be eligible for this clinical trial. You can withdraw your consent at any time.
Your information may be transferred to countries outside your country of residence, including the United States, which may have different data protection rules.
If you submit any personal information about someone else, you confirm that you have permission to do so.
Please read our Privacy policy for more details.